KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 105 filers reported holding KEROS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,014 | -5.9% | 299,000 | 0.0% | 0.14% | -24.6% |
| Q1 2023 | $12,767 | -11.1% | 299,000 | 0.0% | 0.19% | -11.2% |
| Q4 2022 | $14,358 | -99.9% | 299,000 | 0.0% | 0.22% | +39.6% |
| Q3 2022 | $11,248,000 | +36.2% | 299,000 | 0.0% | 0.15% | +40.0% |
| Q2 2022 | $8,261,000 | -52.5% | 299,000 | -6.6% | 0.11% | -40.2% |
| Q1 2022 | $17,402,000 | -7.1% | 320,000 | 0.0% | 0.18% | -9.4% |
| Q4 2021 | $18,723,000 | +52.1% | 320,000 | +2.8% | 0.20% | +44.0% |
| Q3 2021 | $12,309,000 | -9.4% | 311,135 | -2.8% | 0.14% | -9.0% |
| Q2 2021 | $13,590,000 | -31.0% | 320,000 | 0.0% | 0.16% | -32.0% |
| Q1 2021 | $19,696,000 | -6.6% | 320,000 | 0.0% | 0.23% | -20.6% |
| Q4 2020 | $21,090,000 | – | 320,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |